Polymorphisms in Complement Factor H and Hemicentin-1 genes in a Japanese population with dry-type age-related

Nobuo Fuse1, Akiko Miyazawa, Mingge Mengkegale

  • 1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. fusen@oph.med.tohoku.ac.jp

Insights

Polymorphisms in the Complement Factor H (CFH) and Hemicentin-1 genes were investigated for association with dry age-related macular degeneration (AMD) in Japanese individuals. Neither gene showed a statistically significant link to dry AMD in this population.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss.
  • Genetic factors play a role in AMD pathogenesis.
  • The Complement Factor H (CFH) and Hemicentin-1 genes are implicated in AMD risk.

Purpose of the Study:

  • To investigate the association between polymorphisms in the CFH gene and Hemicentin-1 gene at the ARMD1 locus and dry AMD.
  • To analyze these genetic variations in a Japanese patient cohort.

Main Methods:

  • A case-control study involving 80 Japanese patients with dry AMD and 196 Japanese controls.
  • Polymerase chain reaction amplification and direct sequencing of specific exons in the CFH and Hemicentin-1 genes.

Main Results:

  • The previously reported CFH Tyr402His variant was not significantly more frequent in AMD patients (P = .31).
  • Three sequence alterations (Asp5088Val, IVS99-13C/T, His5245Gln) were identified in the Hemicentin-1 gene.
  • The Gln5346Arg variant in Hemicentin-1 was not detected.

Conclusions:

  • The studied CFH gene polymorphisms do not appear to be significantly associated with dry AMD in the Japanese population.
  • Hemicentin-1 gene variations investigated in this study are not statistically linked to dry AMD in Japanese individuals.
  • These findings suggest CFH and Hemicentin-1 genes may not contribute significantly to dry AMD pathogenesis in this cohort.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...